|
|
EQSNews: Galimedix, Inc.
/ Key words: Conference
Galimedix Therapeutics presents new scientific data showing promising neuroprotective effects of GAL201 for the treatment of Alzheimer’s disease at AD/PD™ 2024
08.03.2024 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Galimedix, Inc.
/ Key words: Conference
Galimedix Therapeutics announces new preclinical data with GAL201 in an Alzheimers disease transgenic model to be presented at AD/PD™ 2024 Conference
28.02.2024 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Galimedix, Inc.
/ Key words: Personnel
Galimedix Appoints Dr. Luciana Summo as Vice President, R&D Operations news with additional features
25.10.2023 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Galimedix Appoints Dr. Luciana Summo as Vice P... Lire le communiqué |
|
| |
|
| |
